Brimonidine tartrate for the treatment of glaucoma

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma

(2016) B. Chiang et al.   JOURNAL OF CONTROLLED RELEASE

Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection

(2016) Shereen Nizari et al.   Cell Death & Disease

Brimonidine Induced Anterior Uveitis

(2015) Jacqueline Beltz et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Effect of Brimonidine on Retinal Vascular Autoregulation and Short-term Visual Function in Normal Tension Glaucoma

(2014) Gilbert T. Feke et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040

(2014) Yih-Chung Tham et al.   OPHTHALMOLOGY

Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma

(2014) K Semba et al.   Cell Death & Disease

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus

(2014) Quang H. Nguyen   Patient Preference and Adherence

Risk Factors for Visual Field Progression in the Low-pressure Glaucoma Treatment Study

(2012) Carlos Gustavo De Moraes et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results From the Low-pressure Glaucoma Treatment Study

(2011) Theodore Krupin et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Are the pharmacology and physiology of α2adrenoceptors determined by α2-heteroreceptors and autoreceptors respectively?

(2011) Ralf Gilsbach et al.   BRITISH JOURNAL OF PHARMACOLOGY

Update on the role of alpha-agonists in glaucoma management

(2011) Stella Arthur et al.   EXPERIMENTAL EYE RESEARCH

Effect of brimonidine tartrate 0.10% ophthalmic solution on pupil diameter

(2011) Gabi Shemesh et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Pupillometry Study of Brimonidine Tartrate 0.2% and Apraclonidine 0.5%

(2011) Eulogio Besada et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Brimonidine for glaucoma

(2010) Mamun Q Rahman et al.   Expert Opinion On Drug Safety

Brimonidine Hypersensitivity when Switching Between 0.2% and 0.15% Formulations

(2010) Michael Sullivan-Mee et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Diurnal and Nocturnal Effects of Brimonidine Monotherapy on Intraocular Pressure

(2010) John H.K. Liu et al.   OPHTHALMOLOGY

Preservatives in eyedrops: The good, the bad and the ugly

(2010) Christophe Baudouin et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Pigment dispersion syndrome and pigmentary glaucoma - a major review

(2009) Nuwan Niyadurupola et al.   CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics

(2009) Ciro Costagliola et al.   EXPERT OPINION ON PHARMACOTHERAPY

Brimonidine Tartrate 0.15%, Dorzolamide Hydrochloride 2%, and Brinzolamide 1% Compared as Adjunctive Therapy to Prostaglandin Analogs

(2009) Thomas E. Bournias et al.   OPHTHALMOLOGY

Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension

(2008) Douglas G. Day et al.   CURRENT MEDICAL RESEARCH AND OPINION

Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial

(2008) Louis B. Cantor et al.   CURRENT MEDICAL RESEARCH AND OPINION

Absorption of Brimonidine 0.1% and 0.15% Ophthalmic Solutions in the Aqueous Humor of Cataract Patients

(2008) Louis B. Cantor et al.   JOURNAL OF GLAUCOMA